Literature DB >> 19482599

RNA processing in the polyoma virus life cycle.

Yingqun Huang1, Gordon G Carmichael.   

Abstract

Not only is gene regulation in polyoma interesting, but it has also proven to be highly informative and illustrative of a number of novel concepts in gene regulation. Of special interest and importance are the mechanisms by which this virus switches from the expression of early gene products to late gene products after the onset of viral DNA replication. This switch is mediated at least in part by changes in transcription elongation and polyadenylation in the late region, and by the formation and editing of dsRNA in the nucleus. In this review we will summarize the regulation of RNA synthesis and processing during polyoma infection, and will point out in particular those aspects that have been most novel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482599      PMCID: PMC4097024          DOI: 10.2741/3581

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  70 in total

Review 1.  RNA editing by adenosine deaminases that act on RNA.

Authors:  Brenda L Bass
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

2.  Polyoma virus transcription early during productive infection of mouse 3T6 cells.

Authors:  P W Piper
Journal:  J Mol Biol       Date:  1979-06-25       Impact factor: 5.469

3.  Virus-specific RNA in cells productively infected or transformed by polyoma virus.

Authors:  R Kamen; D M Lindstrom; H Shure; R W Old
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

4.  An alternative pathway for gene regulation by Myc.

Authors:  K Peukert; P Staller; A Schneider; G Carmichael; F Hänel; M Eilers
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

5.  Sequences in the polyomavirus DNA regulatory region involved in viral DNA replication and early gene expression.

Authors:  L Dailey; C Basilico
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

6.  Transcription from the polyoma late promoter in cells stably transformed by chimeric plasmids.

Authors:  F G Kern; C Basilico
Journal:  Mol Cell Biol       Date:  1985-04       Impact factor: 4.272

7.  Targeted nuclear antisense RNA mimics natural antisense-induced degradation of polyoma virus early RNA.

Authors:  Z Liu; D B Batt; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

8.  Regulation of polyomavirus transcription by large tumor antigen.

Authors:  W G Farmerie; W R Folk
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Sequences at the capped 5'-ends of polyoma virus late region mRNAs: an example of extreme terminal heterogeneity.

Authors:  A Cowie; C Tyndall; R Kamen
Journal:  Nucleic Acids Res       Date:  1981-12-11       Impact factor: 16.971

10.  Structure of polyoma virus late nuclear RNA.

Authors:  R Treisman; R Kamen
Journal:  J Mol Biol       Date:  1981-05-25       Impact factor: 5.469

View more
  8 in total

1.  Discovery of STL polyomavirus, a polyomavirus of ancestral recombinant origin that encodes a unique T antigen by alternative splicing.

Authors:  Efrem S Lim; Alejandro Reyes; Martin Antonio; Debasish Saha; Usman N Ikumapayi; Mitchell Adeyemi; O Colin Stine; Rebecca Skelton; Daniel C Brennan; Rajhab S Mkakosya; Mark J Manary; Jeffrey I Gordon; David Wang
Journal:  Virology       Date:  2012-12-29       Impact factor: 3.616

2.  RNA editing, epitranscriptomics, and processing in cancer progression.

Authors:  Keren L Witkin; Sean E Hanlon; Jennifer A Strasburger; John M Coffin; Samie R Jaffrey; T Kevin Howcroft; Peter C Dedon; Joan A Steitz; Phil J Daschner; Elizabeth Read-Connole
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

3.  Mutational pressure by host APOBEC3s more strongly affects genes expressed early in the lytic phase of herpes simplex virus-1 (HSV-1) and human polyomavirus (HPyV) infection.

Authors:  Maxwell Shapiro; Laurie T Krug; Thomas MacCarthy
Journal:  PLoS Pathog       Date:  2021-04-30       Impact factor: 6.823

4.  A Comprehensive Analysis of Replicating Merkel Cell Polyomavirus Genomes Delineates the Viral Transcription Program and Suggests a Role for mcv-miR-M1 in Episomal Persistence.

Authors:  Juliane Marie Theiss; Thomas Günther; Malik Alawi; Friederike Neumann; Uwe Tessmer; Nicole Fischer; Adam Grundhoff
Journal:  PLoS Pathog       Date:  2015-07-28       Impact factor: 6.823

5.  Novel Polyomaviruses in Mammals from Multiple Orders and Reassessment of Polyomavirus Evolution and Taxonomy.

Authors:  Bernhard Ehlers; Augustin E Anoh; Nicole Ben Salem; Sebastian Broll; Emmanuel Couacy-Hymann; Daniela Fischer; Alma Gedvilaite; Nanina Ingenhütt; Sonja Liebmann; Maite Martin; Arsene Mossoun; Lawrence Mugisha; Jean-Jacques Muyembe-Tamfum; Maude Pauly; Bernat Pérez de Val; Hannah Preugschas; Dania Richter; Grit Schubert; Claudia A Szentiks; Tamara Teichmann; Cornelia Walter; Rainer G Ulrich; Lidewij Wiersma; Fabian H Leendertz; Sébastien Calvignac-Spencer
Journal:  Viruses       Date:  2019-10-10       Impact factor: 5.048

6.  Identification and characterization of a novel bat polyomavirus in Japan.

Authors:  Ryota Koba; Satori Suzuki; Go Sato; Shingo Sato; Kazuo Suzuki; Soichi Maruyama; Yukinobu Tohya
Journal:  Virus Genes       Date:  2020-08-20       Impact factor: 2.332

Review 7.  Strength in Diversity: Nuclear Export of Viral RNAs.

Authors:  Jón Pol Gales; Julie Kubina; Angèle Geldreich; Maria Dimitrova
Journal:  Viruses       Date:  2020-09-11       Impact factor: 5.048

8.  The Thiazole-5-Carboxamide GPS491 Inhibits HIV-1, Adenovirus, and Coronavirus Replication by Altering RNA Processing/Accumulation.

Authors:  Subha Dahal; Ran Cheng; Peter K Cheung; Terek Been; Ramy Malty; Melissa Geng; Sarah Manianis; Lulzim Shkreta; Shahrazad Jahanshahi; Johanne Toutant; Rose Chan; Sean Park; Mark A Brockman; Mohan Babu; Samira Mubareka; Karen Mossman; Arinjay Banerjee; Scott Gray-Owen; Martha Brown; Walid A Houry; Benoit Chabot; David Grierson; Alan Cochrane
Journal:  Viruses       Date:  2021-12-30       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.